Medtronic (MDT) Capital Expenditures (2014 - 2026)

Medtronic (MDT) has 13 years of Capital Expenditures data on file, last reported at $488.0 million in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 6.32% year-over-year to $488.0 million; the trailing twelve-month figure through Apr 2026 stood at $1.9 billion (up 2.42% YoY), and the FY2026 full-year result was $1.9 billion, up 2.42% from the prior year.
• Capital Expenditures climbed to $488.0 million in Q2 2026, from $444.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $520.0 million in Q3 2024 to a low of $323.0 million in Q4 2022.
• A 5-year average of $418.2 million and a median of $426.0 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures dropped 16.9% in 2023 and surged 46.89% in 2024, its largest moves.
• Tracing MDT's Capital Expenditures over 5 years: stood at $323.0 million in 2022, then soared by 42.72% to $461.0 million in 2023, then dropped by 12.36% to $404.0 million in 2024, then rose by 15.84% to $468.0 million in 2025, then grew by 4.27% to $488.0 million in 2026.
• Business Quant data shows MDT's Capital Expenditures at $488.0 million in Q2 2026, $444.0 million in Q1 2026, and $468.0 million in Q4 2025.